What is Ranibizumab?

Category: Prescription Drugs

Most popular types: Lucentis


Ranibizumab is a vascular endothelial growth factor (VEGF) inhibitor that is used for the treatment of Wet/Neovascular Age-Related Macular Degeneration, Macular Edema Following Retinal Vein Occlusion, and Diabetic Macular Edema.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 2

Commonly reported side effects and conditions associated with Ranibizumab

Side effect Patients Percentage
Eye floaters 1
Eye pain 1
Joint pain 1
Sore throat 1

Why patients stopped taking Ranibizumab

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 1
See 1 patient who's stopped taking Ranibizumab


Stopped taking Ranibizumab

Duration Patients Percentage
6 months - 1 year 1
Adherence Evaluations Percentage
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 2
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 1
$50-99 0
$25-49 0
< $25 0
Not specified 1

What people switch to and from

Patients started taking Ranibizumab after stopping:

Treatment Patients Percentage
Aflibercept (Eylea) 1
Last updated:
There are no evaluations for Ranibizumab.